Collectively, these findings underscore the pivotal role of the AZIN1-polyamine axis in osteosarcoma and support developing immunotherapeutic strategies that target polyamine metabolism to overcome resistance and enhance treatment efficacy. This evidence concerns the gene AZIN1 and osteosarcoma.